Clinical Trial Update: Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating intracameral moxifloxacin to prevent postcataract endophthalmitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endophthalmitis

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Universidade Federal de Pernambuco | Conditions: Endophthalmitis | Phase 2 | Status: COMPLETED